SOZO vs Azra AI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

SOZO

by ImpediMed Limited

Azra AI

by Azra AI

AI Verdict

SOZO and Azra AI are adjacent competitors, both operating within oncology but with distinct functionalities. SOZO focuses on the early detection and management of lymphedema and sarcopenia through bioimpedance spectroscopy and body composition analysis, providing objective data for proactive patient care. Azra AI, on the other hand, is an AI-powered platform that analyzes pathology and radiology reports to identify, classify, and triage cancer patients, streamlining oncology workflows and care coordination. Therefore, the choice between them depends on whether the priority is objective physiological measurement for specific conditions or AI-driven optimization of the cancer patient journey.

Choose SOZO if…

Choose SOZO if your primary need is the early detection and ongoing management of lymphedema, particularly in oncology patients. It is also well-suited for comprehensive body composition analysis, including fluid, fat, and lean mass, to monitor patient health in various specialties like cardiology, nephrology, and medical weight management. The rapid, non-invasive 30-second scan and cloud-based data management make it ideal for efficient, proactive patient care and longitudinal tracking.

View SOZO →

Choose Azra AI if…

Choose Azra AI if your organization requires an AI-powered platform for swift identification, classification, and triaging of cancer patients across various stages, from incidental findings to survivorship. It excels in automating cancer registry processes, streamlining tumor board management, and enhancing patient care coordination and navigation. Azra AI is particularly beneficial for large health systems seeking to optimize oncology workflows, integrate with existing EHRs, and leverage real-time data for clinical trial matching and pre-screening.

View Azra AI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	SOZO	Azra AI
Pricing	Unknown	Custom subscription model
Deployment	Cloud	Cloud, SaaS
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Cleared AI-estimated	Unknown
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

SOZO

SOZO emphasizes a user-friendly experience with a rapid, non-invasive 30-second scan and an intuitive touchscreen interface. It also provides an on-screen guide for clinicians and a patient portal, suggesting a well-considered user journey for both patients and providers.

Clinical Value

Azra AI

Azra AI offers a broader range of clinical applications within oncology, including AI-powered patient identification, incidental findings detection, cancer registry automation, tumor board management, and clinical trial matching. This comprehensive approach addresses multiple critical pain points across the cancer care continuum, demonstrating significant impact on patient outcomes and operational efficiency.

Pricing & Value

Tie

Both tools offer custom or enterprise-level pricing models, making a direct comparison of cost-effectiveness difficult without specific quotes. While Azra AI highlights significant ROI through efficiency gains and improved patient outcomes, SOZO's value is tied to early detection and prevention of lymphedema, which also has long-term cost-saving implications.

Enterprise Readiness

Azra AI

Azra AI is deployed at over 1,500 sites and is integrated with leading EHRs, indicating strong enterprise readiness. It also offers solutions for enterprise oncology standardization and a unified patient intelligence layer, suggesting robust capabilities for large-scale deployments and complex healthcare systems.

Innovation

Azra AI

Azra AI leverages advanced AI for real-time analysis of pathology and radiology reports, incidental findings detection, and agentic AI for clinical research, showcasing a strong innovative edge in applying AI to complex oncology workflows. SOZO's BIS technology is also innovative for lymphedema detection, but Azra AI's breadth of AI applications across the oncology pathway gives it an advantage in overall innovation.

Support & Docs

SOZO

SOZO provides clear instructions for use, assembly, and measurement, along with online help videos and direct contact information for support. While Azra AI's documentation and support details are less publicly available, SOZO's readily accessible resources suggest a more transparent and comprehensive support structure.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	SOZO	Azra AI
Name	SOZO	Azra AI
Description	SOZO by ImpediMed is a non-invasive bioimpedance spectroscopy (BIS) device designed for the early detection and ongoing management of lymphedema, providing rapid L-Dex scores and body composition analysis.	Azra AI is an AI platform that swiftly analyzes, identifies, and classifies cancer patients, triaging those needing therapy and follow-up to enhance oncology care. It is deployed at more than 1,500 sites and integrated with leading EHRs.
Company	ImpediMed Limited	Azra AI
Tagline	The worldu2019s most advanced, non-invasive bioimpedance spectroscopy (BIS) device for lymphedema detection and management.	Solving the Root Causes of Complex Healthcare Challenges
Categories	Clinical Decision Support & Reference, Lab & Diagnostics	Clinical Decision Support & Reference, EMR / EHR Systems, Oncology AI
Specialties	General Surgery, Oncology	Oncology, Pathology, Radiology
Key Features	Bioimpedance Spectroscopy (BIS) technology, L-Dex score for lymphedema assessment, Rapid, non-invasive 30-second scan, Body composition analysis (fluid, fat, lean mass), Cloud-based data management and trend analysis, Wireless connectivity & intuitive touchscreen, Automated reporting, My SOZO patient portal access	AI-powered patient identification (pathology/radiology AI), Incidental findings detection, Cancer registry automation (SmartPathu2122 / Flowu2122), Tumor board management (Compassu2122), Patient care coordination & navigation (Journeyu2122), Real-time data & analytics (Azra IQu2122), Seamless EHR integration, Clinical trial matching and pre-screening

Videos

Demos, reviews, and walkthroughs featuring SOZO and Azra AI.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows and EHR systems, and what is the impact on physician burden?

SOZO is designed for seamless integration into routine intake and follow-up visits, with automated transfer of measurement data directly into the EHR to save time and improve workflow efficiency. Azra AI overlays the EHR with bidirectional integration, transforming clinical data into structured workflows and syncing documented decisions back to the patient record, aiming to reduce manual tasks and enhance patient management.

What is the accuracy and sensitivity of each tool in its respective clinical application?

SOZO's L-Dex score for lymphedema assessment has an area under the curve (AUC) of 0.95 for unilateral assessment and 0.80 for bilateral assessment, with cross-sectional sensitivity of 81.3% and specificity of 91.6%. Azra AI's platform has demonstrated high precision, identifying 99% of positive cancer cases in pathology reports in one health system's analysis.

What is the typical learning curve for physicians and clinical staff, and what kind of support is provided to ensure effective utilization?

SOZO is described as fast, intuitive, and easy to use, with an on-screen guide for clinicians. Azra AI is customized for each health system's workflows and patient population, suggesting an implementation and support process tailored to the user. Both companies aim to simplify complex healthcare challenges and improve user experience.

Beyond HIPAA, what are the security measures in place to protect sensitive patient data, especially given multi-site deployments?

SOZO stores data in a HIPAA-compliant cloud that is encrypted in motion and at rest, and is HiTrust-Certified. Azra AI also utilizes HIPAA-compliant cloud infrastructure and HITRUST standards, with client-specific data isolation through dedicated cloud projects and ongoing compliance monitoring.

What audit-trail features are available to ensure accountability and support compliance or accreditation reporting?

SOZO allows administrators to export audit logs. Azra AI provides a full audit trail for compliance and accreditation reporting, with every AI recommendation and clinician decision timestamped and stored in both Azra AI and the EHR.

How do these tools facilitate multi-site rollouts and ensure consistent care coordination across different locations?

SOZO's cloud-based platform aggregates and analyzes data, making it accessible across an entire healthcare system, which is relevant for larger corporate clients with multiple sites. Azra AI is deployed at over 1,500 sites and is designed to provide enterprise-level insights and governance across multi-facility health systems, ensuring structured oversight and consistent patient management.

Can these tools provide clinical context or insights that directly aid in physician decision-making for patient care?

SOZO provides L-Dex scores for lymphedema assessment and body composition analysis, offering objective data and longitudinal tracking to aid in early detection and management of lymphedema and other conditions. Azra AI uses AI to identify, classify, and triage cancer patients, extracting deep clinical insights like stage, grade, and tumor markers from unstructured data to power oncology workflows and support care coordination and clinical trial matching.